Latest filing published 05 Jun 2023 for ImmunityBio, Inc., €124k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael D. Blaszyk is a declared insider at 2 companies; the most frequent names are ImmunityBio, Inc. and NantHealth, Inc. The record holds 10 filings, for trades running from 13 May 2016 to 5 June 2023.
Every open-market trade on record is a purchase: 3 purchases worth €185k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants. Since January 2023: 3 purchases and no sales on the market.
Half of the purchases are above €59k and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -55.6%. These figures describe past trades and do not predict future prices.
The record was last updated on 5 June 2023 with an open-market purchase (€124k) in ImmunityBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations